Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis

Cancer Biology and Medicine 2026 Open access

Read full text Summarise with VIRAT
Authors: Yi Liu, Dandan Wu, Xing Li, Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao
+1 more Jihui Hao
DOI: 10.20892/j.issn.2095-3941.2025.0848
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest solid tumors. Patients who develop PDAC with locally advanced pancreatic cancer (LAPC) or metastases have an especially poor prognosis[1][1]. Although there have been improvements in systemic therapy, long-term disease control is

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment Intraperitoneal and Appendiceal Malignancies

Publication details

Journal / source
Cancer Biology and Medicine
Volume
23
Issue
6
Pages
1–5
Publication date
16 March 2026
Language
EN